Prediction of adverse pathology in prostate cancer using a multimodal deep learning approach based on [F]PSMA-1007 PET/CT and multiparametric MRI.
Journal:
European journal of nuclear medicine and molecular imaging
Published Date:
Feb 19, 2025
Abstract
PURPOSE: Accurate prediction of adverse pathology (AP) in prostate cancer (PCa) patients is crucial for formulating effective treatment strategies. This study aims to develop and evaluate a multimodal deep learning model based on [F]PSMA-1007 PET/CT and multiparametric MRI (mpMRI) to predict the presence of AP, and investigate whether the model that integrates [F]PSMA-1007 PET/CT and mpMRI outperforms the individual PET/CT or mpMRI models in predicting AP.